We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
156 hedge funds and large institutions have $1.64B invested in Puma Biotechnology in 2018 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 61 increasing their positions, 46 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 46
8% more call options, than puts
Call options by funds: $35.4M | Put options by funds: $32.9M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.19% less ownership
Funds ownership: 95.31% → 94.12% (-1.2%)
10% less funds holding
Funds holding: 174 → 156 (-18)
23% less capital invested
Capital invested by funds: $2.13B → $1.64B (-$486M)
44% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 39
Holders
156
Holders Change
-18
Holders Change %
-10.34%
% of All Funds
3.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
61
Reduced
46
Closed
39
Calls
$35.4M
Puts
$32.9M
Net Calls
+$2.57M
Net Calls Change
+$2.38M
Top Buyers
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$36.2M |
| 2 |
FAM
Fred Alger Management
New York
|
+$24.9M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$19.8M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$15.3M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$13.4M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$55.7M |
| 2 |
PA
Perceptive Advisors
New York
|
-$27.7M |
| 3 |
D.E. Shaw & Co
New York
|
-$25.7M |
| 4 |
Jennison Associates
New York
|
-$22.3M |
| 5 |
TCP
Tourbillon Capital Partners
New York
|
-$16.5M |
